2060 related articles for article (PubMed ID: 6690624)
1. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
Colotta F; Peri G; Villa A; Mantovani A
J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
[TBL] [Abstract][Full Text] [Related]
2. Rapid killing of actinomycin D-treated tumor cells by human monocytes. II. Cytotoxicity is independent of secretion of reactive oxygen intermediates and is suppressed by protease inhibitors.
Colotta F; Bersani L; Lazzarin A; Poli G; Mantovani A
J Immunol; 1985 May; 134(5):3524-31. PubMed ID: 4038989
[TBL] [Abstract][Full Text] [Related]
3. Monocyte-mediated augmentation of human natural killer cell activity: conditions, monocyte and effector cell characteristics.
Bloom ET; Babbitt JT; Kawakami K
J Immunol; 1986 Jul; 137(1):172-8. PubMed ID: 3711665
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor as effector molecule in monocyte mediated cytotoxicity.
Ziegler-Heitbrock HW; Möller A; Linke RP; Haas JG; Rieber EP; Riethmüller G
Cancer Res; 1986 Nov; 46(11):5947-52. PubMed ID: 3756932
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor production by human monocytes is a regulated event: induction of TNF-alpha-mediated cellular cytotoxicity by endotoxin.
Kornbluth RS; Edgington TS
J Immunol; 1986 Oct; 137(8):2585-91. PubMed ID: 3760568
[TBL] [Abstract][Full Text] [Related]
6. Role of monocyte cytotoxic factor in cytolysis of actinomycin D-treated WEHI 164 cells mediated by freshly isolated human adherent mononuclear blood cells.
Austgulen R; Espevik T; Hammerstrøm J; Nissen-Meyer J
Cancer Res; 1986 Sep; 46(9):4566-70. PubMed ID: 3524816
[TBL] [Abstract][Full Text] [Related]
7. Natural cytotoxicity of human blood monocytes and natural killer cells and their cytotoxic factors: discriminating effects of actinomycin D.
Uchida A; Klein E
Int J Cancer; 1985 May; 35(5):691-9. PubMed ID: 3997288
[TBL] [Abstract][Full Text] [Related]
8. The use of VEP13 monoclonal antibody for definition of natural killer cells: spontaneous killer cells directed against fresh human leukaemia cells carry the VEP13 antigen.
Ziegler-Heitbrock HW; Fütterer A; Rumpold H; Kraft D; Munker R; Riethmüller G
Clin Exp Immunol; 1984 Nov; 58(2):470-7. PubMed ID: 6333947
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo interaction between murine fibrosarcoma cells and natural killer cells.
Laybourn KA; Hiserodt JC; Abruzzo LV; Varani J
Cancer Res; 1986 Jul; 46(7):3407-12. PubMed ID: 2939945
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates.
Bonavida B; Lebow LT; Bradley TP
J Immunol; 1984 Feb; 132(2):594-8. PubMed ID: 6606675
[TBL] [Abstract][Full Text] [Related]
11. Suppression of in vitro maintenance and interferon-mediated augmentation of natural killer cell activity by adherent peritoneal cells from normal mice.
Brunda MJ; Taramelli D; Holden HT; Varesio L
J Immunol; 1983 Apr; 130(4):1974-9. PubMed ID: 6187831
[TBL] [Abstract][Full Text] [Related]
12. Natural cytotoxicity against mouse hepatitis virus-infected target cells. I. Correlation of cytotoxicity with virus binding to leukocytes.
Holmes KV; Welsh RM; Haspel MV
J Immunol; 1986 Feb; 136(4):1446-53. PubMed ID: 3003198
[TBL] [Abstract][Full Text] [Related]
13. Purification and target cell range of in vivo elicited blast natural killer cells.
Biron CA; Pedersen KF; Welsh RM
J Immunol; 1986 Jul; 137(2):463-71. PubMed ID: 3722814
[TBL] [Abstract][Full Text] [Related]
14. Tumor-activated NK cells trigger monocyte oxidative metabolism.
Pohajdak B; Gomez JL; Wilkins JA; Greenberg AH
J Immunol; 1984 Nov; 133(5):2430-6. PubMed ID: 6434630
[TBL] [Abstract][Full Text] [Related]
15. Dissociation of responses measured by natural cytotoxicity and chemiluminescence.
Ernst M; Lange A; Flad HD; Havel A; Ennen J; Ulmer AJ
Eur J Immunol; 1984 Jul; 14(7):634-9. PubMed ID: 6430710
[TBL] [Abstract][Full Text] [Related]
16. Antileukemia activity of a natural killer cell line against human leukemias.
Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
[TBL] [Abstract][Full Text] [Related]
17. The cytotoxic effector cells in preparations of adherent mononuclear cells from human peripheral blood.
Freundlich B; Trinchieri G; Perussia B; Zurier RB
J Immunol; 1984 Mar; 132(3):1255-60. PubMed ID: 6693767
[TBL] [Abstract][Full Text] [Related]
18. Natural cytotoxicity against mouse hepatitis virus-infected cells. II. A cytotoxic effector cell with a B lymphocyte phenotype.
Welsh RM; Haspel MV; Parker DC; Holmes KV
J Immunol; 1986 Feb; 136(4):1454-60. PubMed ID: 3003199
[TBL] [Abstract][Full Text] [Related]
19. In vitro generation of human activated lymphocyte killer cells: separate precursors and modes of generation of NK-like cells and "anomalous" killer cells.
Burns GF; Triglia T; Werkmeister JA
J Immunol; 1984 Sep; 133(3):1656-63. PubMed ID: 6611374
[TBL] [Abstract][Full Text] [Related]
20. Natural killer-sensitive targets stimulate production of TNF-alpha but not TNF-beta (lymphotoxin) by highly purified human peripheral blood large granular lymphocytes.
Peters PM; Ortaldo JR; Shalaby MR; Svedersky LP; Nedwin GE; Bringman TS; Hass PE; Aggarwal BB; Herberman RB; Goeddel DV
J Immunol; 1986 Oct; 137(8):2592-8. PubMed ID: 3760569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]